Superluminal Medicines Launches with $33 Million Seed Round to Fuel its Drug Discovery Engine and Pipeline of Small Molecule Therapeutics

<p>Financing led by RA Capital Management with participation from Insight Partners, NVIDIA, and Gaingels Superluminal combines deep biology and chemistry expertise with machine learning built on vast proprietary training sets to create candidate-ready compounds with unprecedented speed Funds to support advancement of pipeline initially focused on high-value GPCR targets, with lead program candidate expected in […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/superluminal-medicines-launches-with-33-million-seed-round-to-fuel-its-drug-discovery-engine-and-pipeline-of-small-molecule-therapeutics/">Superluminal Medicines Launches with $33 Million Seed Round to Fuel its Drug Discovery Engine and Pipeline of Small Molecule Therapeutics</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>